List of Peer-Reviewed Publications
1. Weiner F, Kanter Y, Kol S, Barzilai D. Computer implementation of the new diabetes classification scheme. Meth Inform Med 21:191, 1982. Full text
2. Kanter Y, Kol S, Weiner F. Intravenous glucose tolerance test in gestational diabetes and pregnancy: manual vs. computerized assessment. Eur J Obstet Gynecol Reprod Biol. 27:307, 1988. Full text
3. Barnea ER, Fares F, Kol S. Stimulatory effect of prolactin on human placental progesterone secretion at term in vitro: possible inhibitory effect on estradiol secretion. Placenta 10:37, 1989.
4. Barnea ER, Perlman R, Fakih H, Bick T, Kol S, Hochberg Z. The role of catecholamines in estradiol and progesterone secretion by cultured explants and cells of human term placenta. Acta Endocrinologica 121:767, 1989. Full text
5. Barnea ER, Simon RJ, Kol S, Human embryonal extracts modulate placental function in the first trimester: effect of visceral tissues upon chorionic gonadotropin and progesterone secretion. Placenta 10:331, 1989.
6. Kol S, Gal D, Friedman M, Paldi E. Case report: preoperative diagnosis of fallopian tube carcinoma by TVS and CA-125. Gynecologic Oncology 37:129, 1990. Full text
7. Kol S, Jakobi P, Paldi E. The intrauterine device, a transitional period. Harefua 118:676, 1990. Full text
8. Adir Y, Bitterman H, Kol S, Melamed Y. Hyperbaric oxygen treatment for carbon monoxide intoxication acquired in the sealed room during the Persian Gulf War. Israel Journal of Medical Sciences 27:669, 1991. Full text
9. Barnea ER, Ashkenazy R, Tal Y, Kol S, Sarne Y. Effect of b-endorphin on human chorionic gonadotrophin secretion by placental explants. Hum Reprod 6: 1327, 1991.
10. Jakobi P, Kol S, Weissman A, Krivoy N. Peripartum changes in free and protein bound digoxin like immuno-reactive factor. J Reprod Med 37:127, 1992.
11. Adir Y, Kol S, Melamed Y. Carbon monoxide and coronary artery disease. Harefuah, 122:249, 1992. Full text
12. Nachum Z, Kol S, Adir Y, Melamed Y. Massive air embolism - a possible cause of death after operative hysteroscopy using a 32% dextran 70 pump. Fertil Steril 58:836, 1992. Full text
13. Kol S, Ammar R, Weisz G, Melamed Y. Hyperbaric oxygenation for arterial air embolism during cardiopulmonary bypass. Ann Thorac Surg, 55:401, 1993. Full text
14. Kol S, Weisz G, Melamed Y. Pulmonary barotrauma after a free dive - a possible mechanism. Aviat Space Environ Med 64:236, 1993. Full text
15. Kol S, Levron J, Lewit N, Drugan A, Itskovitz-Eldor J. The natural history of multiple pregnancies after assisted reproduction: Is spontaneous fetal reduction a clinically significant phenomenon? Fertil Steril 60:127, 1993. Full text
16. Kol S, Adir Y, Gordon CR, Melamed Y. Oxy-helium treatment of severe spinal decompression sickness after air diving. Undersea Biomed Res 20:147, 1993. Full text
17. Itskovitz-Eldor J, Levron J, Kol S. Use of GnRH-agonist to cause ovulation and prevent ovarian hyperstimulation sundrome. Clin Obstet Gynecol, 36:701, 1993. Full text
18. Aharon-Peretz J, Adir Y, Gordon CR, Kol S. Gal N, Melamed Y. Spinal Decompression sickness in sport diving. Arch Neurol 50:753, 1993. Full text
19. Kol S, Gordon CR, Melamed Y. The potential role of oxygen in the prevention of neurologic deficit after cardiac surgery. Intensive & Critical Care Digest 12:48, 1993. Full text
20. Payne DW, Shackeleton C, Toms H, Ben-Shlomo I, Kol S, deMoura M, Strauss JF, Adashi EY. A novel nonhepatic hydroxycholosterol 7ahydroxylase that is markedly stimulated by interleukin-1b J Biol Chem 270:18888-96, 1995. Full text
21. Kol S, Thaler I, Paz N, Shmueli O. Interpretation of nonstress tests by an artificial neural network. Am J Obstet Gynecol 172:1372, 1995. Full text
22. Kol S, Ben-Shlomo I, Adashi EY, Rohan RM. Simplified riboprobe purification using starslucent straws as gel tubes. Gen Alalysis 1996;12:129-132. Full text
23. Ben-Shlomo I, Kol S, Ando M, Altman KR, Putowski LT, Rohan RM, Adashi EY Ovarian expression, cellular localization, and hormonal regulation of rat secretory phospholipase A2: increased expression by interleukin-1 and by gonadotropins. Biol Reprod 1997;57:217-225. Full text
24. Scherzer WJ, Putowski LT, Kol S, Adashi EY, Rohan RM. Detection and In Vitro Hormonal Regulation of Rat Ovarian Type I and Type II Interleukin-1 Receptor mRNA: Increased Expression During the Periovulatory Period. J Soc Gyn Invest 1996;3:131-9. Full text
25. Kol S, Ben-Shlomo I, Ruutianen K, Ando M, Resnick CE, Rohan RM, Adashi EY.The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. J Clin Invest 1997, 99:2274-2283. Full text
26.Kol S, Ben-Shlomo I, Payne DW, Ando M, Rohan RM, Adashi EY. Glucocorticoids suppress basal (but not interleukin-1-supported) ovarian phospholipase A2 activity: evidence for glucocorticoid receptor-mediated regulation.Mol Cell Endocrinol 137:117-25, 1998 Full text
27. Ben-Shlomo I, Kol S, Roeder LM, Resnick CE, Hurwitz A, Payne DW, Adashi EY. Interleukin (IL)-1b Increases Glucose Uptake and Induces Glycolysis in aerobically Cultured Rat Ovarian Cells: Evidence that IL-1b may Mediate the Gonadotropin-Induced Midcyle Metabolic Shift. Endocrinology 1997;138:2680-2688. Full text
28. Kol S, Ben-Shlomo I, Ando M, Payne DW, Adashi EY. Interleukin-1b Stimulates Ovarian Phospholipase A2 (PLA2) Expression and Activity: Up-regulation of Both Secretory and Cystosolic PLA2. Endocrinology 1997;138: 314-321. Full text
29. Kol S, Ruutiainen K, Ben-Shlomo I, Ando M, Payne DW, Adashi EY. The Rat Ovarian Phospholipase A2 System: Gene Expression, Cellular Localization, Activity Characterization, and Interleukin-1 Dependence. Endocrinology 1997;138:322-331. Full text
30. Kol S, Lewit N, Itskovitz-Eldor J. Ovarian Hyperstimulation Syndrome after using Gonadotropin-releasing Hormone Agonist as a Trigger of Ovulation: Causes and implications. Hum Reprod 11:1143, 1996. Full text
31. Lewit N, Kol S, Itskovitz-Eldor J. Does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome? Fertil Steril 66:654, 1996. Full text
32. Lewit N, Kol S, Manor D, Itskovitz-Eldor J. Comparison of GnRH Analogs And Hcg For The Induction of Ovulation And Preventation of Ovarian Hyperstimulation Syndrome (OHSS): A Case-control Study. Hum Reprod 11:1399, 1996. Full text
33. Lewit N, Kol S, Manor D, Itskovitz-Eldor J. The Use of GnRH Analogues For the Induction of Preovulatory Gonadotropin Surge In Assisted Reproduction and Prevention of Ovarian Hyperstimulation Syndrome. Gynecol Endocrinol 9 (Suppl) 4:13-17, 1995. Full text
34. Lightman A, Kol S, Wayner V, Vertman D, Manor D, Itskovitz-Eldor J. The presence of a sponsoring embryo in a batch of poor quality thawed embryos significantly increases pregnancy and implantation rate. Fertil Steril 67:711-6, 1997. Full text
35. Kol S, Karnieli E, Kraiem Z, Itskovitz-Eldor J, Lightman A, Ish-Shalom S. Thyroid function in early normal pregnancy: transient suppression of thyroid stimulating hormone, and stimulation of triiodothyronine. Gyncol Obstet Invest 42:227-229, 1996. Full text
36. Manor D, Kol S, Lewit N, Lightman A, Stein D, Pillar M, Itskovitz-Eldor J. Undocumented embryos: Do not trash them, FISH them. Hum Reprod 11:2502-2506, 1996. Full text
37. Itskovitz-Eldor J, Filmar S, Manor D, Stein D, Lightman A, Kol S. Assisted implantation: Direct intra-endometrial embryo transfer. Gyncol Obstet Invest 43:73-75, 1997. Full text
38. Kent-First MG, Kol S, Muallem A, Manor D, Blazer S, First N, Itskovitz-Eldor J. The incidence and possible relevance of Y-linked microdeletions in ICSI derived babies and their infertile fathers. Mol Hum Reprod 2:943-950, 1996. Full text
39. Itskovitz-Eldor J, Kol S, Lewit N, Sealey JE. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 82:461-464, 1997. Full text
40. Shupak A, Melamed Y, Ramon Y, Bentur Y, Abramovich A, Kol S. Helium and oxygen treatment of severe air diving-induced neurologic decompression sickness. Arch Neurol 54:305-311, 1997. Full text
41.Derman SG, Kol S, Ben-Shlomo I, Resnick CE, Rohan RM, Adashi EY. Transforming growth factor-beta1 is a potent inhibitor of interleukin-1beta action in whole ovarian dispersates. J Endocrinol 160:415-423, 1999. Full text
42.Kol S, Ben-Shlomo1 I, Ando M, Adashi1 EY. Insulin-like growth factor I affects the intraovarian interleukin-1 system: evidence for suppression of type I interleukin-1 receptor expression and enhancement of secretory phospholipase A2 expression and activity. Mol Hum Reprod 1997, 3:1095-1099. Full text
43. Ando M, Kol S, Kokia E, Ruutiainen-Altman K, Sirois J, Rohan RM, Payne DW, Adashi EY. Rat ovarian prostaglandin endoperoxide synthase-1 and -2: periovulatory expression of granulosa cell-based interleukin-1-dependent enzymes. Endocrinology 139:2501-8, 1998. Full text
44. Itskovitz-Eldor J, Kol S, Mannaerts B, Coelingh Bennink H. First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462). Hum Reprod 13:294-5, 1998. Full text
45. Kol S, Ben-Shlomo I, Ando M, Adashi EY. Insulin-like growth factor I affects the intraovarian interleukin-1 system: evidence for suppression of type I interleukin-1 receptor expression and enhancement of secretory phospholipase A2 expression and activity.Mol Hum Reprod 3:1095-9, 1997. Full text
46. Kol S, Donesky BW, Ruutiainen-Altman K, Ben-Shlomo I, Irahara M, Ando M, Rohan RM, Adashi EY. Ovarian Interleukin-1 Receptor Antagonist in Rats: Gene Expression, Cellular Localization, Cyclic Variation, and Hormonal Regulation of a Potential Determinant of Interleukin-1 Action. Biol Reprod 61:274-282, 1999. Full text
47. Kol S, Ruutiainen-Altman K, Scherzer WJ, Ben-Shlomo I, Ando M, Rohan RM, Adashi EY. The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1beta and of the type I and type II IL-1 receptors. Mol Cell Endocrinol 149:115-28, 1999. Full text
48. Coffler MS, Kol S, Drugan A, Itskovitz-Eldor J Early transvaginal embryo aspiration: a safer method for selective reduction in high order multiple gestations. Hum Reprod 14:1875-1878, 1999. Full text
49. Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B, and Itskovitz-Eldor J. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze–thaw cycles . Hum Reprod 14:2242-2244, 1999. Full text
50. Lightman A, Kol S, Itskovitz-Eldor J. A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles. Hum Reprod 14:2596-2599, 1999. Full text
51. Ando M, Kol S, Irahara M, Sirois J, Adashi EY. Non-steroidal anti-inflammatory drugs (NSAIDs) block the late, prostanoid-dependent/ceramide-independent component of ovarian IL-1 action: implications for the ovulatory process. Mol Cell Endocrinol 157:21-30, 1999. Full text
52. Irahara M, Ando M, Kol S, Adashi EY. Expression and hormonal regulation of rat ovarian interleukin-1beta converting enzyme, a putative apoptotic marker: endocrine- and aracrine-dependence. J Reprod Immunol 45:67-79, 1999. Full text
53. Kol S, Wong KH, Ando M, Ben-Shlomo I, Adashi EY. Rat ovarian interleukin-1alpha: interleukin-1-dependent in vitro expression. Endocrine 11:269-75, 1999. Full text
54. Kol S, Itskovitz-Eldor J. Severe OHSS: Yes, there is a strategy to prevent it! Hum Reprod 2000 Webtrack (1.8.2000). Full text
55. Kol S. GnRH antagonists in ART: lower embryo implantation? Hum Reprod; 5:1881-1882, 2000 Webtrack (12.6.2000). Full text
56. Lewit N, Kol S. The low responder female IVF patient with hypogonadotropic hypogonadism: do not give up! Fertil Steril 74:401-2, 2000. Full text
57. Beloosesky R, Kol S Lightman A, Itskovitz-Eldor J. Ovarian stimulation in in vitro fertilization with or without the "long" gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome. Fertil Steril 74:166-8, 2000. Full text
58. Itskovitz-Eldor J, Kol S Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication. Hum Reprod 15:1965-1968, 2000. Full text
59. Kol S, Itskovitz-Eldor J. Severe OHSS: yes, there is a strategy to prevent it! Hum Reprod. 15:2266-7, 2000. Full text
60. Kol S, Should we explore OHSS full clinical scope?... Hum Reprod. 16:595-6, 2001. Full text
61. Kol S, Kehat I, Adashi EY. Ovarian interleukin-1-induced gene expression: privileged genes threshold theory. Med Hypotheses. 58:6-8, 2002. Full text
62. Nevo O, Eldar-Geva T, Kol S, Itskovitz-Eldor J. Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin. Fertil Steril 79:1123-8, 2003. Full text
63. Kol S. Vascular endothelial growth factor - mediator of PHSS? Fertil Steril 79:1466, 2003. Full text
64. Kol S. Prediction of ovarian hyperstimulation syndrome: why predict if we can prevent! Hum Reprod.18:1557-8. 2003. Full text
65. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 81:1-5, 2004. Full text
66. Kol S, Muchtar M. Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further reseach. Reproductive BioMedicine Online 10:575-577, 2005. Full text
67. Kol S. To add or not to add LH: consideration of LH concentration changes in individual patients. Reproductive BioMedicine Online 11:664-666, 2005. Full text
68. Kol S, Solt I. GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy? Journal of Assisted Reproduction and Genetics 25:63-66, 2008. Full text
69. Kol S, Homburg R. Change, change, change: hormonal actions depend on changes in blood levels. Human Reproducion 23:1004-6, 2008. Full text
70. Kol S, Dor J. Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation. Reproductive BioMedicine Online 1:59-60, 2009 Full text, See also.
